Literature DB >> 12121954

Incidence, epidemiology, and characteristics of quinolone-nonsusceptible Streptococcus pneumoniae in Croatia.

Glenn A Pankuch1, Bülent Bozdogan, Kensuke Nagai, Arjana Tambić-Andrasević, Slavko Schoenwald, Tera Tambić, Smilja Kalenić, Sanja Plesko, Nastja K Tepes, Zdenka Kotarski, Marina Payerl-Pal, Peter C Appelbaum.   

Abstract

Among 585 Streptococcus pneumoniae strains isolated in 22 Croatian hospitals 21 strains (3.6%) were quinolone nonsusceptible. MICs of all quinolones were high for seven strains tested with the same serotype (23F) and mutations in gyrA, parC, and parE. The remaining 14 strains were more heterogeneous and had mutations only in parC and/or parE, and the MICs of quinolones were lower for these strains.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12121954      PMCID： PMC127330          DOI： 10.1128/AAC.46.8.2671-2675.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities.

Authors:  M Loeb; A McGeer; M McArthur; S Walter; A E Simor
Journal:  Arch Intern Med       Date:  1999-09-27

2.  Antipneumococcal activities of gemifloxacin compared to those of nine other agents.

Authors:  T A Davies; L M Kelly; G A Pankuch; K L Credito; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae.

Authors:  K Nagai; T A Davies; G A Pankuch; B E Dewasse; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 4.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

5.  Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study.

Authors:  M R Jacobs; S Bajaksouzian; A Zilles; G Lin; G A Pankuch; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

6.  Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

Authors:  D K Chen; A McGeer; J C de Azavedo; D E Low
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245

7.  Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000.

Authors:  P L Ho; R W Yung; D N Tsang; T L Que; M Ho; W H Seto; T K Ng; W C Yam; W W Ng
Journal:  J Antimicrob Chemother       Date:  2001-11       Impact factor: 5.790

8.  Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland.

Authors:  C Jokinen; L Heiskanen; H Juvonen; S Kallinen; M Kleemola; M Koskela; M Leinonen; P R Rönnberg; P Saikku; M Stén; A Tarkiainen; H Tukiainen; K Pyörälä; P H Mäkelä
Journal:  Clin Infect Dis       Date:  2001-03-23       Impact factor: 9.079

9.  Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.

Authors:  N P Brenwald; M J Gill; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

10.  Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management.

Authors:  S L Block; C J Harrison; J A Hedrick; R D Tyler; R A Smith; E Keegan; S A Chartrand
Journal:  Pediatr Infect Dis J       Date:  1995-09       Impact factor: 2.129
View more
  5 in total

1.  High genetic diversity of ciprofloxacin-nonsusceptible isolates of Streptococcus pneumoniae in Poland.

Authors:  Ewa Sadowy; Radosław Izdebski; Anna Skoczyńska; Marek Gniadkowski; Waleria Hryniewicz
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

2.  In vitro activity of DX-619, a novel des-fluoro(6) quinolone, against a panel of Streptococcus pneumoniae mutants with characterized resistance mechanisms.

Authors:  Paul A Wickman; Ellen Smith Moland; Jennifer A Black; Kenneth S Thomson
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Antipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporin.

Authors:  Klaudia Kosowska; Dianne B Hoellman; Gengrong Lin; Catherine Clark; Kim Credito; Pamela McGhee; Bonifacio Dewasse; Bülent Bozdogan; Stuart Shapiro; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

4.  In vitro activity of garenoxacin against Streptococcus pneumoniae mutants with characterized resistance mechanisms.

Authors:  Kazuko Yamamoto; Katsunori Yanagihara; Kazuyuki Sugahara; Yoshifumi Imamura; Masafumi Seki; Koichi Izumikawa; Hiroshi Kakeya; Yoshihiro Yamamoto; Yoichi Hirakata; Shimeru Kamihira; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

5.  Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.

Authors:  Lionel A Mandell; John G Bartlett; Scott F Dowell; Thomas M File; Daniel M Musher; Cynthia Whitney
Journal:  Clin Infect Dis       Date:  2003-11-03       Impact factor: 9.079
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.